Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance
about
Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophagesEffect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureusMutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosisMutant prevention concentration as a measure of fluoroquinolone potency against mycobacteriaMycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacinCloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosisQuinolone-induced upregulation of osteopontin gene promoter activity in human lung epithelial cell line A549.Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae.Activity of and resistance to moxifloxacin in Staphylococcus aureus.Eagle Effect in Nonreplicating Persister MycobacteriaFluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.Powerful bactericidal activity of moxifloxacin in human leprosy.Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group.Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae.Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus.Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase.Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.Comparison of aqueous humour concentration after single high dose versus multiple administration of topical moxifloxacin in rabbits.In vitro model of mycobacterial growth arrest using nitric oxide with limited air.Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolatesComparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones.Induction of mycobacterial resistance to quinolone class antimicrobialsFluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis.Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.Contribution of the C-8-methoxy group of gatifloxacin to inhibition of type II topoisomerases of Staphylococcus aureus.Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones.Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones.Suppression of reactive-oxygen-species accumulation accounts for paradoxical bacterial survival at high quinolone concentration.
P2860
Q28343182-6C9656F3-FA08-4C2A-AF76-DE32215D24D5Q28343420-93610920-16D2-4E31-83FD-7F22F5133BB2Q28344614-482AAE27-F4C4-435B-BC0D-AC5440C32E7AQ28344939-6EAF7904-1DB4-407E-847C-BCA7EF76C115Q28486678-01BA07BF-0564-4B8A-BDB1-3E050BAA2818Q28486897-7ACEEEB0-7FA2-4721-8C8D-9E14632C72EAQ30394542-AADD0143-EA56-4D55-9948-2FFFCA1082F8Q33805682-5749FD52-6D77-4BDB-B968-0776DE1D1DB8Q33983092-4C3FA785-C20D-4A57-8C7B-71F97EE5143AQ34106465-1D26E18E-4981-4A7E-936F-579561B0CCCBQ34721556-279558D3-848C-46C2-A5C3-B0CC27658E8AQ34885313-CF400016-DF7F-48DE-8BF4-101DAB1D00F5Q36290556-FD4782BD-4845-4F4E-B9A5-310F892A88B2Q36607348-8B671667-E835-4AAE-8C9F-48BDA0D9AE16Q36607637-8306AC4A-17D7-464A-A909-C5A342B84088Q36870814-2F59A4E6-3A53-4049-B422-B06CE14DADAFQ37187468-29D5A41C-D93E-46C7-9F3F-29C66926DE8DQ39472413-534D0BDC-C6F5-4584-8ECD-3EA4830755E3Q39477371-5C251941-4968-4B72-938A-51A2CBAE3DC2Q39477717-24F97EB5-F08A-4391-9CB6-8A1680ABC452Q39478440-EF3081C1-C1C0-4831-A862-184AEEFDB9D6Q39651272-B7EB1A6B-03B2-4B23-A845-DC93ABAEA001Q39683413-C2208829-1CEA-4A5C-9842-CCBED6429CD1Q39792565-42CFAA19-DEC6-4221-B05E-151C3F697520Q40469459-F494BD79-366D-4281-86AD-39124EE483D1Q41647773-731CE797-9A0E-4C1C-8F44-02AEFF893398Q41844976-BE0739E4-0307-460C-B158-939062B050E2Q41975822-8D086E9B-8C3B-419B-9D98-01F74DBF99DAQ42183775-971BE39C-84FB-4DD8-82DB-068EA9720916Q42210567-7D271996-5133-42FF-93C6-DA5716BD5639Q42727166-DEF87813-8AD1-4F8F-8DF4-AC786710AAE3Q42727522-2A8D4E96-C558-47BE-868D-09BC728818A5Q42730708-486678C7-B041-470A-82B8-37ACC2DE7755Q42784827-6551F2D2-1D9A-4D0B-9CEE-F58E3A94718DQ43245973-74E535D1-8501-4C4F-954B-D12B4983CD3BQ43251107-1D14B7A0-0D8C-45D0-9428-7E330EC3B5A5Q46243490-7E4146A4-7196-4DD7-833E-9D407D6046CA
P2860
Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Fluoroquinolone action against ...... owth, survival, and resistance
@ast
Fluoroquinolone action against ...... owth, survival, and resistance
@en
Fluoroquinolone action against ...... owth, survival, and resistance
@nl
type
label
Fluoroquinolone action against ...... owth, survival, and resistance
@ast
Fluoroquinolone action against ...... owth, survival, and resistance
@en
Fluoroquinolone action against ...... owth, survival, and resistance
@nl
prefLabel
Fluoroquinolone action against ...... owth, survival, and resistance
@ast
Fluoroquinolone action against ...... owth, survival, and resistance
@en
Fluoroquinolone action against ...... owth, survival, and resistance
@nl
P2093
P2860
P356
P1476
Fluoroquinolone action against ...... owth, survival, and resistance
@en
P2093
P2860
P304
P356
10.1128/AAC.42.11.2978
P407
P577
1998-11-01T00:00:00Z